However, stopping these therapies often leads to significant weight regain, frustrating patients and clinicians alike.[1][2] Understanding GLP-1 Agonists GLP-1 drugs mimic the gut hormone glucagon-like peptide-1, which regulates blood sugar and appetite
Several programs offer reduced costs for those willing to pay directly
For GLP-1 drugs, the risks include: Increased anxiety or panic from unstable blood sugar Triggering or worsening depression Heightened risk of obsessive eating behaviors Potential for self-esteem issues or body image dysmorphia For someone already struggling with mental health, these risks are compounded making proper medical oversight essential
Don't hesitate to reach out to your doctor if you're struggling with side effects
People with any of the following conditions should not take semaglutide: A personal or family history of medullary thyroid carcinoma A personal history of multiple endocrine neoplasia syndrome type 2 An allergic reaction to semaglutide or any of its ingredients Pregnant women 6
5 Mounjaro subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity or overweight, however studies have shown that it may be associated with weight loss in individuals with type 2 diabetes